Astral Systems raises $27.6M Series A (United Kingdom, Jun 2026)
$27.6M
€26 million Series AGenerated social card
Headline
Bristol's Astral Systems secures €26 million Series A to support medical isotope commercialisation - EU-Startups
About
Astral Systems is a British DeepTech firm that specializes in pioneering multi-state fusion technology. The company aims to produce critical medical isotopes for diagnosis, treatment, and research, addressing the fragile supply chain and potential global shortages in this area.
Article summary
Bristol's Astral Systems secures €26 million Series A to support medical isotope commercialisation EU-Startups
Founder
Talmon Firestone
CEO and co-founder
Investors · 6
4 hiddenRelated rounds
| Aug 12, 2026 | Cytix | $6.4M | Series A | United Kingdom |
| Aug 12, 2026 | Pyra | $200.0M | — | United Kingdom |
| Aug 10, 2026 | — | — | United Kingdom | |
| Aug 10, 2026 | Cambridge Aerospace | $300.0M | — | United Kingdom |